Profusa Inc
profusa.comWhat Do They Do?
Develops injectable biosensors and data tools that measure tissue oxygen and glucose for wound-care clinicians and people with diabetes.
10-K for FY2025, filed Apr 15, 2026Profusa is a digital health technology company based in Berkeley, California, that has invested over the last twelve years more than $100…View ↗
Near term product revenue in Europe from the CE approved Lumee Oxygen which measures dissolved tissue oxygen for up to six months following…View ↗
Future product revenues from Profusa’s second product, Lumee Glucose, a continuous glucose monitoring platform, that will provide real time…View ↗
How Do They Make Money?
Profusa has earned product-sale revenue from oxygen sensors for research use, including animal models and in vitro testing.
10-K for FY2025, filed Apr 15, 2026In 2024, we sold our oxygen sensor for research use only applications, namely animal models and in vitro testing. Management is targeting…View ↗
$100K
-
10-K for FY2025, filed Apr 15, 2026
$100K ↗
Who Are Their Customers?
Profusa plans to sell Lumee Oxygen directly to medical facilities, based on recommendations from specialists treating peripheral artery disease and critical limb ischemia. It has also sold research-use sensors to entities working with animal models.
10-K for FY2025, filed Apr 15, 2026
Do Revenues Turn Into Profits?
No. It lost $9.2M in FY2024.
10-K for FY2025, filed Apr 15, 2026
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 19, 2026
−$8.8MView ↗
- ▲ +273% (Loss)
- vs −$2.3M in Q2 FY2025
-
Jul 31, 2026
Profusa signed an option to acquire G3 and its subsidiaries
The option depends on financing and other conditions; G3 owns or controls three diagnostics companies.
Sources
8-K, filed Jul 31, 2026
The Option Agreement provides the Company with the right, but not the obligation (the “Call Option”), to acquire from the Sellers all of…View ↗
From acquisition vehicle to biosensors
The older report described NorthView as a blank-check company seeking a healthcare business combination; the latest describes Profusa as developing biosensors for medical monitoring.
10-K for FY2022, filed Mar 6, 2023 10-K for FY2025, filed Apr 15, 2026We are a blank check company formed under the laws of the State of Delaware April 19, 2021. We were formed for the purpose of effecting a…View ↗
Profusa is a digital health technology company based in Berkeley, California, that has invested over the last twelve years more than $100…View ↗
Near term product revenue in Europe from the CE approved Lumee Oxygen which measures dissolved tissue oxygen for up to six months following…View ↗
Future product revenues from Profusa’s second product, Lumee Glucose, a continuous glucose monitoring platform, that will provide real time…View ↗
Who Do They Compete With?
Competes with Philips, Siemens Healthineers, Perimed, Radiometer Medical, SenTec, Dexcom, Abbott, Medtronic, Senseonics, Diamontech, Movano, and Nemaura Medical
10-K for FY2025, filed Apr 15, 2026Examples of such technologies include digital subtraction angiography devices developed by Philips or Computed Tomography (CT) for…View ↗
Loading...
